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We describe a recent development of the OntoGene Relation Miner system (OG-RM), aimed at the automatic extraction of 
drug/gene/diseases  relationships  from the  biomedical  literature.  The  OG-RM system was  developed  originally for  the 
extraction of protein-protein interactions (PPI) from the biomedical literature [1]. The system has been tested in a controlled 
setting by participation to the PPI tasks of the BioCreative II and BioCreative II.5 competitive evaluations of text mining 
systems [2,3]. Recently, within the context of the SASEBio project (a collaboration between the OntoGene group at the 
University of Zurich and the NITAS/TMS group of Novartis Pharma AG), the OntoGene Relation Miner has been extended 
in order to deal with larger classes of entities and relationships. In particular,  terminology for drugs and diseases has been 
derived from the Pharmacogenomics Knowledge Base (PharmGKB) [4]. 
The OntoGene system takes as input a document, provided either in plain text or in a number of supported xml formats (e.g. 
PubMed Central),  and, after conversion to an internal xml-based format, applies a number of processing steps, enriching it 
with different categories of annotations. The processing steps include standard linguistic preprocessing (sentence boundary 
detection, tokenization, lemmatization, part-of-speech tagging), named entity recognition, phrase chunking, and syntactic 
parsing (using our own dependency-based parser)  [5].  Entities detected in the input document are disambiguated with 
respect to a reference database (UniProt for proteins, EntrezGene for genes, NCBI taxonomy for species, PSI-MI ontology 
for experimental methods, PharmGKB for drugs and diseases). Drugs and disease names present a lower ambiguity degree 
compared to proteins and genes, however some problematic cases remain (e.g. "Leukemia" can be used as a term for 32 
distinct diseases, according to PharmGKB).
Candidate  interactions  are  generated  on  the  basis  of  co-occurrence  in  a  specified  text  unit.  Validation  of  candidate 
interactions is based on a combination of local and global information. In particular, the presence of some salient clue words 
in the local context, and the syntactic structure of the fragment of the sentence connecting the candidate interactants, are 
used as indicators of relevance. Global information, such as frequency of mentions of the interactants in the paper, is further 
used for weighting purposes. As in the case of the BioCreative setup, not all relationships mentioned in a paper are relevant,  
but  solely those  that  are  reported  by the  authors  as  their  main  research  results.  The  identification  of  such  'curatable' 
interactions  is  based  on  a  classifier  which  attempts  to  distinguish  sentences  that  report  background information  from 
sentences  that  describe  novel  results.  While  PharmGKB  would  allow  construction  of  a  test  corpus  of  26122 
drug/disease/gene relationship over a set of 5062 distinct PubMed articles, in practice our experiments are limited by the 
absence of a common full text format. Currently we are evaluating the effectiveness of our approach using a manually 
selected subset of those articles. Detailed results will be presented at the workshop. 
Although it is impossible to automatically reproduce the relationship annotations provided by PharmGKB, we think that 
advanced text mining techniques will soon be accepted as an important support tool for the curation process. To this aim, we 
have also developed a customizable interface (ODIN: OntoGene Document Inspector) which allows an effective interaction 
of the human curator with the underlying text mining system. A presentation/demo will be provided at the workshop. 
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